Dow Down 0.17% Nasdaq Down 0.28%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
4.26 0.26(5.75%) Sep 30, 4:00PM EDT
Prev Close:4.52
Open:4.55
Bid:4.21 x 300
Ask:4.43 x 200
1y Target Est:11.00
Beta:1.61
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:4.23 - 4.59
52wk Range:4.23 - 7.82
Volume:5,427,878
Avg Vol (3m):3,781,790
Market Cap:521.99M
P/E (ttm):N/A
EPS (ttm):-0.84
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OREXDown 5.75%521.99M
ABT62.54B
GSK110.42B
RHHBY251.34B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):161.57
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.23
Quarterly EPS Est (Sep-14) :0.06
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-1.73

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback